1.7.10 Oncogene Amplification Definition
Oncogene amplification is a selective increase in the copy number of an oncogene, boosting its expression and driving tumor cell proliferation.
Oncogene Amplification Definition is the description of an increase in the number of copies of an oncogene present within a cancer cell's genome, arising from abnormal duplication of the chromosomal segment containing that gene, resulting in production of a correspondingly greater quantity of the gene's protein product and an amplified growth-promoting signal within the cell. Oncogene amplification achieves oncogenic activation through an increase in gene dosage rather than through any structural alteration of the protein encoded by the affected gene, meaning that the amplified protein is typically identical in sequence to the normal, unaltered protein, differing only in its overall abundance.
Conceptual Basis of Oncogene Amplification
A Quantitative Mechanism of Activation
Oncogene amplification represents a purely quantitative mechanism of oncogenic activation, in contrast to mechanisms such as point mutation that alter the structure of the encoded protein. The abnormal growth-promoting effect produced by amplification arises entirely from the increased quantity of an otherwise normal protein, rather than from any change to that protein's intrinsic biochemical properties.
Localized Nature of the Genomic Increase
Oncogene amplification typically affects a limited, defined segment of a chromosome surrounding the amplified gene, rather than involving duplication of an entire chromosome, distinguishing this focal form of copy number increase from broader chromosomal gains that can occur through other mechanisms of genomic instability.
Structural Forms of Oncogene Amplification
Amplification Within the Chromosome
In one structural form of oncogene amplification, the additional copies of the amplified gene remain integrated within their original chromosome, arranged as a tandem series of repeated segments positioned adjacent to one another along the chromosomal DNA.
Amplification as Extrachromosomal Elements
In an alternative structural form of oncogene amplification, the additional copies of the amplified gene become organized into small, circular fragments of DNA that exist independently of the normal chromosomes, replicating and segregating separately from the rest of the genome during cell division.
Mechanisms Producing Oncogene Amplification
Errors During DNA Replication
Oncogene amplification can arise from errors occurring during the replication of DNA, in which a segment of the genome is copied more than once within a single round of replication, producing additional copies of the genes contained within that segment.
Breakage-Fusion-Bridge Cycles
Oncogene amplification can also arise through repeated cycles in which a broken chromosome end fuses with another broken end, forms an unstable structure during cell division, and breaks again, progressively duplicating the genetic material located near the site of the original break across successive cell divisions.
Consequences of Oncogene Amplification
Overproduction of the Encoded Protein
The direct consequence of oncogene amplification is production of the encoded protein at a level substantially higher than would occur from the normal, unamplified gene, resulting in an amplified growth-promoting signal proportional to the degree of gene copy number increase.
Enhanced Sensitivity to Otherwise Limiting Signals
Overproduction of a growth-promoting protein resulting from oncogene amplification can allow a cell to respond to growth signals present at levels that would be insufficient to trigger a comparable response in a cell with a normal, unamplified copy number of that gene.
Significance of Oncogene Amplification Within Cancer Cell Biology
A Recurrent and Identifiable Category of Oncogenic Activation
Amplification of specific oncogenes is observed recurrently across particular cancer types, and the degree of amplification, along with the identity of the amplified gene, is frequently used as a molecular marker for characterizing tumors and for informing the selection of therapies specifically targeting the overproduced protein.